Clinical trial
Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme' Hypofractionation
NCT06894628 is registered in ClinicalTrials.gov with Regina Elena Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme' Hypofractionation
- Lead sponsor
- Regina Elena Cancer Institute
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 4, 2024
- Completion date
- November 4, 2027
- Enrollment
- 103 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.